Development of LNA Gapmer Oligonucleotide-Based Therapy for ALS/FTD Caused by the C9orf72 Repeat Expansion. (2020)
Attributed to:
UoOxford Confidence in Concept 2013
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-1-0716-0771-8_14
PubMed Identifier: 32865792
Publication URI: http://europepmc.org/abstract/MED/32865792
Type: Journal Article/Review
Volume: 2176
Parent Publication: Methods in molecular biology (Clifton, N.J.)
ISSN: 1064-3745